products.hero.eyebrow
products.hero.heading1 products.hero.heading2 products.hero.heading3
products.hero.body
products.isolates.eyebrow
products.isolates.heading
products.isolates.body
99.9% PureTHCA
THCA Isolate
Crystalline Powder
Our flagship isolate. Tetrahydrocannabinolic acid in its purest pharmaceutical form — neuroprotective, anti-inflammatory, and precisely dosed for clinical micro-dosing protocols.
99.9% PureCBDA
CBDA Isolate
Crystalline Powder
Cannabidiolic acid with powerful serotonin-modulating properties. Formulated for patients managing anxiety, PTSD, and treatment-related nausea.
99.9% PureCBGA
CBGA Isolate
Crystalline Powder
The "mother cannabinoid" — the biosynthetic precursor to all major cannabinoids. CBGA supports metabolic function and serves as the foundation of our compound formulas.
99.9% PureCBCA
CBCA Isolate
Crystalline Powder
Cannabichromenic acid — emerging research points to its role in neurogenesis and antimicrobial activity. A key component in our neurological disorder protocols.
99.9% PureCBNA
CBNA Isolate
Crystalline Powder
Cannabinolic acid with sedative and appetite-stimulating properties. Integral to our oncology support and chronic pain compound formulas.
products.dosing.eyebrow
products.dosing.heading
products.dosing.body
Single Isolate Dosing Ranges
| products.dosing.isolate | products.dosing.startingDose | products.dosing.targetRange | Max Daily | products.dosing.route |
|---|---|---|---|---|
| THCA | 2.5 mg | 5–25 mg/day | 50 mg/day | Sublingual / Oral |
| CBDA | 5 mg | 10–40 mg/day | 80 mg/day | Sublingual / Oral |
| CBGA | 5 mg | 10–50 mg/day | 100 mg/day | Oral |
| CBCA | 2.5 mg | 5–20 mg/day | 40 mg/day | Sublingual / Oral |
| CBNA | 1 mg | 2–10 mg/day | 20 mg/day | Sublingual (evening) |
Compound Formula Dosing Guidance
NeuroCalm Formula
Schedule
Twice daily — morning and evening
Titration
Begin at 5 mg total cannabinoids. Titrate by 2.5 mg every 5–7 days.
Maintenance
15–40 mg/day total cannabinoids
Clinical Notes
Evening dose may be increased for patients with sleep-related neurological symptoms.
Serenity Formula
Schedule
Once or twice daily — afternoon and/or evening
Titration
Begin at 5 mg total cannabinoids. Titrate by 2.5 mg every 7 days.
Maintenance
10–30 mg/day total cannabinoids
Clinical Notes
CBNA content makes evening dosing preferable for patients with sleep disruption.
Oncology Support Formula
Schedule
Three times daily — with meals
Titration
Begin at 2.5 mg total cannabinoids per dose. Titrate weekly under physician supervision.
Maintenance
15–60 mg/day total cannabinoids
Clinical Notes
Dosing should be coordinated with oncology team. Adjust around chemotherapy cycles.
Inflammation Protocol Formula
Schedule
Twice daily — morning and evening with food
Titration
Begin at 5 mg total cannabinoids. Titrate by 5 mg every 5–7 days.
Maintenance
20–60 mg/day total cannabinoids
Clinical Notes
Higher doses may be appropriate for acute inflammatory episodes under physician direction.
products.formulas.eyebrow
products.formulas.heading
products.formulas.body
FC-N01NeuroCalm Formula
A precision-blended compound targeting neuroprotection and pain modulation. Formulated for patients with epilepsy, MS, Parkinson's, and neuropathic pain.
FC-S02Serenity Formula
Designed for the nervous system under chronic stress. Combines serotonin-modulating CBDA with calming CBNA for patients navigating PTSD and anxiety disorders.
FC-O03Oncology Support Formula
A comprehensive adjunct formula for patients in active cancer treatment. Addresses nausea, appetite loss, pain, and inflammation with a full-spectrum cannabinoid acid blend.
FC-I04Inflammation Protocol
Targeted anti-inflammatory action for systemic and localized inflammation. Suitable for autoimmune conditions, arthritis, and post-surgical recovery.
products.personalizedCta.heading
products.cta.heading
products.personalizedCta.body
5
Cannabinoid Isolates
4+
Compound Formulas
99.9%
Purity Standard
6+
Conditions Treated